eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
6/2021
vol. 38
 
Share:
Share:
more
 
 
abstract:
Letter to the Editor

Potential therapeutic role of pharmacological sympathectomy in Martorell ulcer

Mirko Baglivo
1
,
Manuela Baronio
2
,
Nina Arnelle Dieumo Ngongan
3
,
Stefano Romagnoli
4
,
Raffaele De Gaudio
4
,
Matteo Bertelli
5

1.
Research Unit, MAGI-EUREGIO, Bolzano, Italy
2.
Department of Anaesthesia and Intensive Care, Fondazione Poliambulanza, Brescia, Italy
3.
Grand Hôpital de l’Est Francilien, Paris, France
4.
Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
5.
Research Unit, EBTNA-Lab, Rovereto, Italy
Adv Dermatol Allergol 2021; XXXVIII (6): 1112-1114
Online publish date: 2022/01/07
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Martorell ulcer (MU) is a rare complication of arterial hypertension. It was first described in 1945 by the Spanish cardiologist Fernando Martorell, who reported 4 clinical cases [1]. A few cases of MU have been treated with pharmacological sympathectomy [2]. Here we report another small group of cases of MU treated in this manner. Sixteen patients with MU, aged 69 to 92 years, were selected. A precise diagnosis of MU was made by checking the Martorell diagnostic inclusion criteria: anterolateral site in the lower third of the leg, diastolic hypertension in the lower third of the leg, hyperpulsation of the arteries of the leg, absence of arterial calcification and other causes of the ulcer, possible presence of symmetrical lesions and stronger pain in the horizontal position [1].
Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.